Silk Road Medical, Inc
SILK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $2 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 27.8% | 36.6% | 34.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 71.7% | 72.7% | 74.9% | 71.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -25.4% | -33.7% | -44.9% | -55.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -31.5% | -41.8% | -49.7% | -67% |
| EPS Diluted | -1.44 | -1.62 | -1.45 | -1.53 |
| % Growth | 11.1% | -11.7% | 5.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |